The FDA issued a warning regarding the Rotarex Atherectomy System, a device used to break up and remove the thrombus from peripheral arteries. Bard Peripheral Vascular, a subsidiary of Becton, ...
The FDA is getting the word out on a high-risk issue related to artery-clearing catheters from BD’s Bard Peripheral Vascular division. According to the agency, BD has reported 30 serious injuries and ...
The US Food and Drug Administration is alerting the public of a potentially high-risk device issue related to Rotarex Atherectomy Systems (Bard Peripheral Vascular) used in peripheral artery ...
Becton, Dickinson and Company (BD) is set to initiate a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, aimed at measuring real-world outcomes for individuals with peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results